TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has shared an update.
Giant Biogene Holding Co., Ltd. has announced a special cash dividend of RMB 0.5921 per share for the financial year ending December 31, 2024, with the payment to be made in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.09357. This announcement reflects the company’s robust financial performance and commitment to delivering value to its shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$93.70 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd. operates in the biotechnology industry, focusing on the development and production of bioactive materials and skincare products. The company is known for its innovative solutions in the health and beauty sector, catering to a diverse market with a strong emphasis on research and development.
Average Trading Volume: 9,738,363
Technical Sentiment Signal: Buy
Current Market Cap: HK$63.45B
See more data about 2367 stock on TipRanks’ Stock Analysis page.